These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4459391)

  • 1. Dose response studies with Wistar RA 27/3 strain live attenuated rubella vaccine.
    Zealley H; Morrison AM; Freestone DS
    J Biol Stand; 1974 Apr; 2(2):111-9. PubMed ID: 4459391
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials carried out to assess non-parenteral routes for administration of Wistar RA 27/3 strain live attenuated rubella vaccine.
    Freestone DS
    Dev Biol Stand; 1976; 33():237-40. PubMed ID: 782973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States.
    Plotkin SA; Farquhar JD; Ogra PL
    JAMA; 1973 Aug; 225(6):585-90. PubMed ID: 4740523
    [No Abstract]   [Full Text] [Related]  

  • 4. Persistence of rubella antibodies 15 years after subcutaneous administration of Wistar 27/3 strain live attenuated rubella virus vaccine.
    Hillary IB; Griffith AH
    Vaccine; 1984 Dec; 2(4):274-6. PubMed ID: 6531967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic response to revaccination with two rubella vaccines.
    Brandling-Bennett AD; Jackson RS; Halstead SB; Campbell CC; Herrmann KL; Modlin JF; Meyers JD; Witte JJ
    Am J Dis Child; 1976 Oct; 130(10):1081-4. PubMed ID: 973610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity to intranasal challenge with Rubella virus two years after vaccination: comparison of three vaccines.
    Grillner L
    J Infect Dis; 1976 Jun; 133(6):637-41. PubMed ID: 932491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative trial of HPV-77, DE-5 and RA 27-3 live-attenuated rubella vaccines.
    Wallace RB; Isacson P
    Am J Dis Child; 1972 Oct; 124(4):536-8. PubMed ID: 4562789
    [No Abstract]   [Full Text] [Related]  

  • 8. Intranasal versus subcutaneous rubella vaccination in schoolgirls.
    Midulla M; Assensio AM; Balducci L; Vanni O; Msstropasqua S
    Dev Biol Stand; 1976; 33():241-8. PubMed ID: 955270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination of schoolgirls against rubella. Assessment of serological status and a comparative trial of Wistar RA 27/3 and Cendehill strain live attenuated rubella vaccines in 13-year-old schoolgirls in Dudley.
    Freestone DS; Reynolds GM; McKinnon JA; Prydie J
    Br J Prev Soc Med; 1975 Dec; 29(4):258-61. PubMed ID: 766879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous and intranasal administration of RA 27-3 rubella vaccine. Alone and in conjunction with live attenuated measles vaccine.
    Saidi S; Naficy K
    Am J Dis Child; 1969 Aug; 118(2):209-12. PubMed ID: 5794816
    [No Abstract]   [Full Text] [Related]  

  • 11. Specific immunoglobulin responses in serum and nasal secretions after the administration of attenuated rubella vaccine.
    Cradock-Watson JE; Macdonald H; Ridehalgh MK; Bourne MS; Vandervelde EM
    J Hyg (Lond); 1974 Aug; 73(1):127-41. PubMed ID: 4608331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to wild and vaccine rubella viruses after rubella vaccination.
    Cusi MG; Metelli R; Valensin PE
    Arch Virol; 1989; 106(1-2):63-72. PubMed ID: 2764728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On vaccination against rubella with live attenuated virus (strain RA 27-3)].
    Monaci V; Giovannelli G; Nardi G; Siegert V; Tanzi ML; Bellelli E; Chiusi O
    Ann Sclavo; 1974; 16(3):231-42. PubMed ID: 4473961
    [No Abstract]   [Full Text] [Related]  

  • 14. Intranasal administration of RA 27/3 rubella virus vaccine. A clinical trial in young adults.
    Paradise JE; Nemorofsky D; Huggins GR; Sondheimer SJ; Plotkin SA
    J Adolesc Health Care; 1984 Apr; 5(2):75-8. PubMed ID: 6368506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of the humoral immunity conferred by RA 27-3 rubella vaccine.
    Montagnon B; Boué A; Nicolas A; Tayot JL; Peyron L; Servajean B
    Biomedicine; 1973 Nov; 19(11):495-8. PubMed ID: 4599840
    [No Abstract]   [Full Text] [Related]  

  • 16. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; McLean AA; Hilleman MR
    Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rubella screening in school girls using the radial hemolysis test and their vaccination with attenuated live vaccine of the RA23/3 strain].
    Strauss J; Benes C; Macátová I
    Z Gesamte Hyg; 1988 Oct; 34(10):589-91. PubMed ID: 3201803
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic stability in humans of the rabbit immunogenic marker of Cendehill rubella vaccine virus.
    Gill SD; Furesz J
    Arch Gesamte Virusforsch; 1973; 43(1):135-43. PubMed ID: 4793528
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vaccination against rubella. A comparison of intranasal and subcutaneous aadministration of the vaccination strain RA 27-3 (author's transl)].
    Petersen EE; Büche M; Doerr HW; Neumann-Haefelin C; Luthardt T; Göttsching C; Haas R
    Dtsch Med Wochenschr; 1973 Oct; 98(40):1842-7. PubMed ID: 4762037
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccination by non-parenteral routes: characteristics of immune response.
    Ogra PL; Chiba Y; Beutner KR; Morag A
    Dev Biol Stand; 1976; 33():19-26. PubMed ID: 782968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.